Location History:
- Saitama, JP (2005)
- Tokyo, JP (2000 - 2007)
- Toshima-ku, JP (2011 - 2012)
Company Filing History:
7 out of 314 
1 out of 181 
8 out of 832,880 Years Active: 2000-2012
Title: Shigeyuki Chaki: Innovator in Pharmaceutical Development
Introduction
Shigeyuki Chaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for various mental and physical health conditions. With a total of 15 patents to his name, Chaki's work has the potential to impact many lives.
Latest Patents
Among his latest innovations are phenylpyrazole derivatives, which serve as prophylactic or therapeutic agents for a range of conditions including dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, and allergic rhinitis. These derivatives are represented by a specific formula, which includes pharmaceutically acceptable salts.
Career Highlights
Chaki has worked with notable companies in the pharmaceutical industry, including Taisho Pharmaceutical Co., Ltd. His expertise in drug development has positioned him as a key figure in the advancement of treatments for complex health issues.
Collaborations
Throughout his career, Chaki has collaborated with esteemed colleagues such as Atsuro Nakazato and Kazuyuki Tomisawa. These partnerships have fostered innovation and have contributed to the success of his projects.
Conclusion
Shigeyuki Chaki's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through research and development. His work continues to pave the way for new therapeutic options in the medical field.